{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:19:42Z","timestamp":1787764782091,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s10620-006-8015-x","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T01:32:54Z","timestamp":1153531974000},"page":"1103-1112","source":"Crossref","is-referenced-by-count":49,"title":["Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen\/Progestin"],"prefix":"10.1007","volume":"51","author":[{"given":"Robert H.","family":"Boone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa M.","family":"Girlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jenny","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"8015_CR1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","volume":"14","author":"R Eastell","year":"1991","unstructured":"1. Eastell R, Dickson ER, Hodgson SF, et al.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296\u2013300, 1991","journal-title":"Hepatology"},{"key":"8015_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","volume":"118","author":"JE Springer","year":"2000","unstructured":"2. Springer JE, Cole DE, Rubin LA, et al.: Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145\u2013151, 2000","journal-title":"Gastroenterology"},{"key":"8015_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","volume":"103","author":"SF Hodgson","year":"1985","unstructured":"3. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL: Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855\u2013860, 1985","journal-title":"Ann Intern Med"},{"key":"8015_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","volume":"7","author":"AJ Stellon","year":"1987","unstructured":"4. Stellon AJ, Webb A, Compston J, Williams R: Low bone turnover state in primary biliary cirrhosis. Hepatology 7:137\u2013142, 1987","journal-title":"Hepatology"},{"key":"8015_CR5","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"CH Janes","year":"1995","unstructured":"5. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581\u20132586, 1995","journal-title":"J Clin Invest"},{"key":"8015_CR6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/8756-3282(93)90310-7","volume":"14","author":"SF Hodgson","year":"1993","unstructured":"6. Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant SC, Riggs BL: Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 14:819\u2013827, 1993","journal-title":"Bone"},{"key":"8015_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840040101","volume":"4","author":"JA Cuthbert","year":"1984","unstructured":"7. Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B: Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4:1\u20138, 1984","journal-title":"Hepatology"},{"key":"8015_CR8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","volume":"36","author":"MM Guichelaar","year":"2002","unstructured":"8. Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE: Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometry. Hepatology 36:895\u2013903, 2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"8015_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0168-8278(02)80558-X","volume":"36","author":"A Pares","year":"2002","unstructured":"9. Pares A, Guanabens N, Ros I, et al.: Duration and severity of the disease but not menopausal status are the main risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 36(Suppl 1):154\u2013155, 2002","journal-title":"J Hepatol"},{"key":"8015_CR10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"RE Poupon","year":"1997","unstructured":"10. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113:884\u2013890, 1997","journal-title":"Gastroenterology"},{"key":"8015_CR11","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","volume":"29","author":"RE Poupon","year":"1999","unstructured":"11. Poupon RE, Bonnand AM, Chretien Y, Poupon R: Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 29:1668\u20131671, 1999","journal-title":"Hepatology"},{"key":"8015_CR12","first-page":"389","volume":"21","author":"KD Lindor","year":"1995","unstructured":"12. Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER: Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? Hepatology 21:389\u2013392, 1995","journal-title":"Hepatology"},{"key":"8015_CR13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-200201270-00012","volume":"73","author":"J Tinmouth","year":"2002","unstructured":"13. Tinmouth J, Tomlinson G, Heathcote EJ, Lilly L: Benefit of transplantation in primary biliary cirrhosis between 1985\u20131997. Transplantation 73:224\u2013227, 2002","journal-title":"Transplantation"},{"key":"8015_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/bega.2000.0108","volume":"14","author":"FH Wolfhagen","year":"2000","unstructured":"14. Wolfhagen FH, van Buuren HR, Vleggaar FP, Schalm SW: Management of osteoporosis in primary biliary cirrhosis. Ballieres Best Pract Res Clin Gastroenterol 14:629\u2013641, 2000","journal-title":"Ballieres Best Pract Res Clin Gastroenterol"},{"key":"8015_CR15","first-page":"S1","volume":"167","author":"JP Brown","year":"2002","unstructured":"15. Brown JP, Josse RG, and the Scientific Advisory Council of the Osteoporosis Society of Canada: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 Suppl):S1\u201334, 2002","journal-title":"CMAJ"},{"key":"8015_CR16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199009273231305","volume":"323","author":"B Dawson-Hughes","year":"1990","unstructured":"16. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S: A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878\u2013883, 1990","journal-title":"N Engl J Med"},{"key":"8015_CR17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2265.1982.tb02769.x","volume":"16","author":"GF Jensen","year":"1982","unstructured":"17. Jensen GF, Christiansen C, Transbol I: Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen\/gestagen, 1,25-dihydroxy-vitamin D3 and calcium. Clinical Endocrinology 16:515\u2013524, 1982","journal-title":"Clinical Endocrinology"},{"key":"8015_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","volume":"83","author":"HF Herlong","year":"1982","unstructured":"18. Herlong HF, Recker RR, Maddrey WC: Bone disease in primary biliary cirrhosis: Histologic features and response to 25-hydroxyvitamin D. Gastroenterology 83:103\u2013108, 1982","journal-title":"Gastroenterology"},{"key":"8015_CR19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0016-5085(80)90865-3","volume":"78","author":"JS Reed","year":"1980","unstructured":"19. Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL: Bone disease in primary biliary cirrhosis: Reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology 78:512\u2013517, 1980","journal-title":"Gastroenterology"},{"key":"8015_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajcn\/36.3.426","volume":"36","author":"O Epstein","year":"1982","unstructured":"20. Epstein O, Kato Y, Dick R, Sherlock S: Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 36:426\u2013430, 1982","journal-title":"Am J Clin Nutr"},{"key":"8015_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","volume":"83","author":"DS Matloff","year":"1982","unstructured":"21. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ: Osteoporosis in primary biliary cirrhosis: Effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 83:97\u2013102, 1982","journal-title":"Gastroenterology"},{"key":"8015_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-8278(91)90941-4","volume":"12","author":"A Floreani","year":"1991","unstructured":"22. Floreani A, Chiaramonte M, Giannini S, et al.: Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. J Hepatol 12:217\u2013223, 1991","journal-title":"J Hepatol"},{"issue":"3","key":"8015_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","volume":"20","author":"M Camisasca","year":"1994","unstructured":"23. Camisasca M, Crosignani A, Battezzati PM, et al.: Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 20(3):633\u2013637, 1994","journal-title":"Hepatology"},{"key":"8015_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-199706000-00012","volume":"24","author":"A Floreani","year":"1997","unstructured":"24. Floreani A, Zappala F, Fries W, et al.: A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. J Clin Gastroenterol 24:239\u2013244, 1997","journal-title":"J Clin Gastroenterol"},{"key":"8015_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(90)91801-G","volume":"336","author":"JC Stevenson","year":"1990","unstructured":"25. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI: Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 336:265\u2013269, 1990","journal-title":"Lancet"},{"issue":"5B","key":"8015_CR26","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/0002-9343(91)90245-S","volume":"91","author":"BL Riggs","year":"1991","unstructured":"26. Riggs BL: Treatment of osteoporosis with sodium fluoride or parathyroid hormone. Am J Med 91(5B):37S\u201341S, 1991","journal-title":"Am J Med"},{"key":"8015_CR27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0168-8278(92)90066-X","volume":"15","author":"N Guanabens","year":"1992","unstructured":"27. Guanabens N, Pares A, del Rio L, et al.: Sodium fluoride prevents bone loss in primary biliary cirrhosis. J Hepatol 15:345\u2013349, 1992","journal-title":"J Hepatol"},{"key":"8015_CR28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0168-8278(00)80118-X","volume":"33","author":"KD Lindor","year":"2000","unstructured":"28. Lindor KD, Jorgensen RA, Tiegs RD, Khosla S, Dickson ER: Etidronate for osteoporosis in primary biliary cirrhosis: A randomized trial. J Hepatol 33:878\u2013882, 2000","journal-title":"J Hepatol"},{"key":"8015_CR29","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","volume":"98","author":"N Guanabens","year":"2003","unstructured":"29. Guanabens N, Pares A, Ros I, et al.: Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 98:2268\u20132274, 2003","journal-title":"Am J Gastroenterol"},{"key":"8015_CR30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","volume":"102","author":"F Colina","year":"1992","unstructured":"30. Colina F, Pinedo F, Solis JA, Moreno D, Nevado M: Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 102:1319\u20131324, 1992","journal-title":"Gastroenterology"},{"key":"8015_CR31","doi-asserted-by":"crossref","unstructured":"31. Writing Group for the Women's Health Initiative I: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial [comment] [summary for patients in CMAJ. 2002 Aug 20;167(4):377\u20138; PMID: 12197697]. JAMA 288:321\u2013333, 2002","DOI":"10.1001\/jama.288.3.321"},{"key":"8015_CR32","doi-asserted-by":"crossref","unstructured":"32. PEPI Writing G: Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen\/progestin interventions (PEPI) trial. The Writing Group for the PEPI [comment]. JAMA 276:1389\u20131396, 1996","DOI":"10.1001\/jama.1996.03540170033029"},{"key":"8015_CR33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","volume":"288","author":"HD Nelson","year":"2002","unstructured":"33. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD: Postmenopausal hormone replacement therapy: Scientific review [comment]. JAMA 288:872\u2013881, 2002","journal-title":"JAMA"},{"key":"8015_CR34","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","volume":"285","author":"DJ Torgerson","year":"2001","unstructured":"34. Torgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials [comment]. JAMA 285:2891\u20132897, 2001","journal-title":"JAMA"},{"key":"8015_CR35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.1840030422","volume":"3","author":"AJ Schreiber","year":"1983","unstructured":"35. Schreiber AJ, Simon FR: Estrogen-induced cholestasis: Clues to pathogenesis and treatment. Hepatology 3:607\u2013613, 1983","journal-title":"Hepatology"},{"key":"8015_CR36","first-page":"47","volume":"89","author":"JS Crippin","year":"1994","unstructured":"36. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD: Hepatic osteodystrophy in primary biliary cirrhosis: Effects of medical treatment. Am J Gastroenterol 89:47\u201350, 1994","journal-title":"Am J Gastroenterol"},{"key":"8015_CR37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.1840070420","volume":"7","author":"JM Guattery","year":"1987","unstructured":"37. Guattery JM, Faloon WW: Effect of estradiol upon serum enzymes in primary biliary cirrhosis. Hepatology 7:737\u2013742, 1987","journal-title":"Hepatology"},{"key":"8015_CR38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1572-0241.2003.07341.x","volume":"98","author":"KV Menon","year":"2003","unstructured":"38. Menon KV, Angulo P, Boe GM, Lindor KD: Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis. Am J Gastroenterol 98:889\u2013892, 2003","journal-title":"Am J Gastroenterol"},{"key":"8015_CR39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1478-3231.1999.tb00034.x","volume":"19","author":"R Olsson","year":"1999","unstructured":"39. Olsson R, Mattsson LA, Obrant K, Mellstrom D: Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 19:188\u2013192, 1999","journal-title":"Liver"},{"key":"8015_CR40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","volume":"19","author":"SP Pereira","year":"2004","unstructured":"40. Pereira SP, O'Donohue J, Moniz C, et al.: Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: Results of a 1-year controlled trial. Aliment Pharmacol Ther 19:563\u2013570, 2004","journal-title":"Aliment Pharmacol Ther"},{"key":"8015_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","volume":"256","author":"S Ormarsd\u00f3ttir","year":"2004","unstructured":"41. Ormarsd\u00f3ttir S, Mallmin H, Naessen T, et al.: An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. J Intern Med 256:63\u201369, 2004","journal-title":"J Intern Med"},{"issue":"4 Suppl","key":"8015_CR42","first-page":"42S","volume":"75","author":"C Ribot","year":"1990","unstructured":"42. Ribot C, Tremollieres F, Pouilles JM, Louvet JP, Peyron R: Preventive effects of transdermal administration of 17beta-estradiol on postmenopausal bone loss: A 2 year prospective study. Obstet Gynecol 75(4 Suppl):42S\u201346S, 1990","journal-title":"Obstet Gynecol"},{"key":"8015_CR43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-98-2-195","volume":"98","author":"HL Judd","year":"1983","unstructured":"43. Judd HL, Meldrum DR, Deftos LJ, Henderson BE: Estrogen replacement therapy: Indications and complications. Ann Intern Med 98:195\u2013205, 1983","journal-title":"Ann Intern Med"},{"key":"8015_CR44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.1840200120","volume":"20","author":"PA Murtaugh","year":"1994","unstructured":"44. Murtaugh PA, Dickson ER, Van Dam GM, et al.: Primary biliary cirrhosis: Prediction of short-term survival based on repeated patient visits. Hepatology 20:126\u2013134, 1994","journal-title":"Hepatology"},{"key":"8015_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/073993302753428401","volume":"23","author":"SM Reece","year":"2002","unstructured":"45. Reece SM: Weighing the cons and pros: Women's reasons for discontinuing hormone replacement therapy. Health Care Women Int 23:19\u201332, 2002","journal-title":"Health Care Women Int"},{"key":"8015_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1300\/J010v28n03_06","volume":"28","author":"JB Jones","year":"1999","unstructured":"46. Jones JB: Hormone replacement therapy: Women's decision-making process. Soc Work Health Care 28:95\u2013111, 1999","journal-title":"Soc Work Health Care"},{"key":"8015_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","volume":"117","author":"EG Lufkin","year":"1992","unstructured":"47. Lufkin EG, Wahner HW, O'Fallon WM, et al.: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1\u20139, 1992","journal-title":"Ann Intern Med"},{"key":"8015_CR48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM199110243251701","volume":"325","author":"RL Prince","year":"1991","unstructured":"48. Prince RL, Smith M, Dick IM, et al.: Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 325:1189\u20131195, 1991","journal-title":"N Engl J Med"},{"key":"8015_CR49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9378(87)90203-1","volume":"156","author":"BJ Riis","year":"1987","unstructured":"49. Riis BJ, Thomsen K, Strom V, Christiansen C: The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 156:61\u201365, 1987","journal-title":"Am J Obstet Gynecol"},{"key":"8015_CR50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","volume":"113","author":"N Guanabens","year":"1997","unstructured":"50. Guanabens N, Pares A, Monegal A, et al.: Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 years. Gastroenterology 113:219\u2013224, 1997","journal-title":"Gastroenterology"},{"key":"8015_CR51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"51. Meunier PJ, Roux C, Seeman E, et al.: The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis [see comment]. N Engl J Med 350:459\u2013468, 2004","journal-title":"N Engl J Med"},{"key":"8015_CR52","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1359\/jbmr.1998.13.11.1755","volume":"13","author":"SA Jamal","year":"1998","unstructured":"52. Jamal SA, Browner WS, Bauer DC, Cummings SR: Intermittent use of nitrates increases bone mineral density: The study of osteoporotic fractures. J Bone Miner Res 13:1755\u20131759, 1998","journal-title":"J Bone Miner Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-8015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-006-8015-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-8015-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T10:18:06Z","timestamp":1587118686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-006-8015-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["8015"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-8015-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}